Despite Pfizer’s vaccine receiving full approval from the FDA, children under 12 are unlikely to be eligible for a dose until the end of the year, the NIH director says.
from U.S. News - News https://ift.tt/2WdPcWp
from Yahoo News - Latest News & Headlines https://ift.tt/R2Yrilm
0 comments:
Post a Comment